Fumoleau, Pierre <br/><br/>
A phase I pharmacokinetics study of lapatinib and tamoxifen in metastatic breast cancer (EORTC 10053 Lapatam study).  [electronic resource] 

 -  Breast (Edinburgh, Scotland)  Oct 2014 
 - 663-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-3080 
<br/><br/><label>Standard No.: </label>10.1016/j.breast.2014.07.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--blood<br/>Biomarkers, Tumor--metabolism<br/>Breast Neoplasms--blood<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Lapatinib<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Quinazolines--administration & dosage<br/>Receptors, Estrogen--metabolism<br/>Receptors, Progesterone--metabolism<br/>Tamoxifen--administration & dosage<br/>Treatment Outcome